ArticleTherapeutic advances in neurological disorders2024

Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials.

Tobias Derfuss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.